- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2006 (2006), Article ID 39508, 8 pages
Targeting Gonadotropins: An Alternative Option for Alzheimer Disease Treatment
1Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA
2Departament de Fisiologia, Facultat de Farmacia, Universitat de Barcelona, Barcelona 08028, Spain
3School of Medicine, University of Wisconsin and William S. Middleton Memorial Veterans Administration, Madison, WI 53705, USA
4Voyager Pharmaceutical Corporation, Raleigh, NC 27615, USA
Received 5 January 2006; Revised 10 May 2006; Accepted 28 June 2006
Copyright © 2006 Gemma Casadesus et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Citations to this Article [9 citations]
The following is the list of published articles that have cited the current article.
- Anil Kumar, and Samrita Dogra, “Neuropathology and therapeutic management of Alzheimer's disease - an update,” Drugs Of The Future, vol. 33, no. 5, pp. 433–446, 2008.
- Emma Ramiro-Puig, Gemma Casadesús, Hyoung-gon Lee, Xiongwei Zhu, Andrew McShea, George Perry, Francisco J. Pérez-Cano, Mark A. Smith, and Margarida Castell, “Neuroprotective effect of cocoa flavonids on in vitro oxidative stress,” European Journal of Nutrition, vol. 48, no. 1, pp. 54–61, 2008.
- Vladan P. Bajic, Biljana Spremo-Potparevic, Lada Živkovic, David J. Bonda, Sandra L. Siedlak, Gemma Casadesus, Hyoung-gon Lee, and Mark A. Smith, “The X-chromosome instability phenotype in Alzheimer’s disease: A clinical sign of accelerating aging?,” Medical Hypotheses, vol. 73, no. 6, pp. 917–920, 2009.
- Adnan Erol, “Are Paradoxical Cell Cycle Activities in Neurons and Glia Related to the Metabolic Theory of Alzheimer's Disease?,” Journal Of Alzheimers Disease, vol. 19, no. 1, pp. 129–135, 2010.
- Joseph Prandota, “Metabolic, immune, epigenetic, endocrine and phenotypic abnormalities found in individuals with autism spectrum disorders, Down syndrome and Alzheimer disease may be caused by congenital and/or acquired chronic cerebral toxoplasmosis,” Research in Autism Spectrum Disorders, vol. 5, no. 1, pp. 14–59, 2011.
- Emily R. Rosario, Jenna C. Carroll, and Christian J. Pike, “Evaluation of the effects of testosterone and luteinizing hormone on regulation of β-amyloid in male 3xTg-AD mice,” Brain Research, vol. 1466, pp. 137–145, 2012.
- Tomihisa Niitsu, Hideki Okamoto, and Masaomi Iyo, “Behavioural and psychological symptoms of dementia in an Alzheimer's disease case successfully treated with natural medicine: association with gonadotropins,” Psychogeriatrics, vol. 13, no. 2, pp. 124–127, 2013.
- Vladan Bajic, Biljana Spremo-Potparevic, Lada Zivkovic, Esma R. Isenovic, and Thomas Arendt, “Cohesion and the aneuploid phenotype in Alzheimer's disease: a tale of genome instability,” Neuroscience & Biobehavioral Reviews, 2015.
- Vladan Bajic, Vesna Mandusic, Elka Stefanova, Ana Bozovic, Radoslav Davidovic, Lada Zivkovic, Andrea Cabarkapa, and Biljana Spremo-Potparevic, “Skewed X-Chromosome Inactivation in Women Affected by Alzheimer's Disease,” Journal Of Alzheimers Disease, vol. 43, no. 4, pp. 1251–1259, 2015.